• We assessed the value of a fraction of hydroxyethyl starch (HES Pz) in reducing the myocardial reperfusion injury in a canine open-chest model in which 1 hour of left anterior descending coronary artery occlusion was followed by 24 hours of reperfusion. Three treatment infusions (5% of blood volume) were compared: Ringer's lactate, serum albumin, and HES Pz (70% of the macromolecules between 100 000 and 1 000 000 d). When compared with Ringer's lactate and albumin, HES Pz significantly reduced the ratio of 24-hour infarct size to pretreatment area at risk (3% vs 19% and 16%, respectively) and myocardial water content (0.5% vs 3% and 1%). Potassium content differences between injured and normal myocardium were significantly less in the infarct regions of animals receiving HES Pz. In the canine model, HES Pz reduced 1-hour myocardial ischemia reperfusion injury significantly.
(Arch Surg. 1990;125:930-934)
Zikria BA, Subbarao C, Oz MC, et al. Hydroxyethyl Starch Macromolecules Reduce Myocardial Reperfusion Injury. Arch Surg. 1990;125(7):930–934. doi:https://doi.org/10.1001/archsurg.1990.01410190128022
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: